SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001697884-22-000018
Filing Date
2022-12-21
Accepted
2022-12-21 08:19:42
Documents
43
Period of Report
2022-10-31

Document Format Files

Seq Description Document Type Size
1 vsbc10q31oct2022.htm   iXBRL 10-Q 353259
2 ex31_1.htm EX-31.1 10525
3 ex31_2.htm EX-31.2 10651
4 ex32_1.htm EX-32.1 4671
5 ex32_2.htm EX-32.2 4648
  Complete submission text file 0001697884-22-000018.txt   1989650

Data Files

Seq Description Document Type Size
6 vsbc-20221031.xsd EX-101.SCH 13964
7 vsbc-20221031_cal.xml EX-101.CAL 23011
8 vsbc-20221031_def.xml EX-101.DEF 16623
9 vsbc-20221031_lab.xml EX-101.LAB 141122
10 vsbc-20221031_pre.xml EX-101.PRE 101416
37 EXTRACTED XBRL INSTANCE DOCUMENT vsbc10q31oct2022_htm.xml XML 223322
Mailing Address 400 SPECTRUM CENTER DR. #1620 IRVINE CA 92618
Business Address 400 SPECTRUM CENTER DR. #1620 IRVINE CA 92618 9492029235
VITASPRING BIOMEDICAL CO. LTD. (Filer) CIK: 0001697884 (see all company filings)

IRS No.: 371836726 | Fiscal Year End: 0131
Type: 10-Q | Act: 34 | File No.: 333-216465 | Film No.: 221476597
SIC: 8731 Services-Commercial Physical & Biological Research